Telehealth General Psychiatry Prescribing: What PMHNPs Can Do in Pennsylvania

If you’re a psychiatrist or psychiatric nurse practitioner exploring telehealth, you’ve probably asked yourself: ‘Can I actually prescribe medications—including controlled substances like Adderall or Xanax—through a video visit?’ The short answer in 2026 is yes, in most cases. But the real answer depends on where your patient is sitting, what you’re prescribing, and whether you’re an MD or an NP.

Telehealth has fundamentally changed psychiatry. During the pandemic, federal and state governments relaxed rules that once required in-person visits before prescribing controlled substances. Many of those flexibilities remain in place today, and some states have made them permanent. For psychiatrists, this means you can evaluate a new patient via secure video, diagnose ADHD or anxiety, and prescribe a stimulant or benzodiazepine—all without ever meeting in person.

But here’s the catch: the rules aren’t uniform. A psychiatrist in Florida can legally prescribe controlled substances for mental health treatment via telehealth under explicit state law. A PMHNP in Texas, however, needs a supervising physician just to prescribe anything, and faces additional restrictions on Schedule II drugs. If you’re practicing across state lines, you’re navigating a patchwork of regulations that change based on your license type, the patient’s location, and the medication class.

This guide breaks down what psychiatrists and PMHNPs can actually do when prescribing via telehealth in 2026—covering federal DEA rules, state-specific prescribing authority, collaborative practice requirements, and how reimbursement works. Whether you’re an established psychiatrist considering telemedicine or a newly certified PMHNP figuring out your scope, here’s what you need to know.

Federal Rules: Can You Prescribe Controlled Substances via Telehealth?

Let’s start with the big question: controlled substances. Many psychiatric medications—stimulants for ADHD, benzodiazepines for anxiety, buprenorphine for opioid use disorder—are Schedule II-V controlled substances. Historically, the Ryan Haight Act (2008) required at least one in-person medical evaluation before a provider could prescribe controlled substances to a patient.

That changed in 2020. When COVID-19 hit, the DEA issued a temporary waiver allowing providers to prescribe controlled substances via telehealth without an initial in-person visit, as long as the evaluation met the standard of care. That waiver has been extended multiple times and, as of early 2026, remains in effect through December 31, 2025 (texasnp.org) (natlawreview.com).

What this means for you:

• Psychiatrists can initiate prescriptions for Schedule II stimulants (Adderall, Ritalin) or benzodiazepines (Xanax, Klonopin) via a video evaluation, nationwide, under the current federal waiver.
• PMHNPs with prescriptive authority (in states that allow it) can do the same, assuming they have their own DEA registration and state law permits.
• You must conduct a proper audio-visual evaluation—phone-only generally doesn’t meet the standard for controlled substances (though some exceptions exist for established patients in certain states).

The uncertainty: The DEA has proposed new permanent rules that could re-impose some in-person requirements, potentially with exceptions for 30-day supply limits or referrals from an in-person clinician (www.nixonpeabody.com). These rules have been in limbo since 2023. Most industry experts expect some level of telehealth prescribing to remain permanently allowed for psychiatry, given the access crisis and bipartisan support. But if you’re building a telemedicine practice around ADHD or anxiety management, stay alert for DEA announcements in late 2024 and early 2025.

Bottom line: As of February 2026, you can legally prescribe controlled substances via telehealth under federal law. Check the DEA website and professional associations (APA, AANP) for updates on permanent rules.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Prescribing Rules: Where It Gets Complicated

Federal law sets the floor, but state law determines what you can actually prescribe and under what conditions. Some states explicitly permit telehealth prescribing of controlled substances for mental health. Others have carve-outs or restrictions. And for PMHNPs, state scope-of-practice laws dictate whether you can prescribe independently or need a collaborating physician.

Let’s look at key states where telehealth psychiatry is booming:

Florida: Telehealth-Friendly for Psychiatrists, Restricted for PMHNPs

Florida is one of the most permissive states for psychiatrists prescribing via telehealth. Florida Statutes explicitly allow controlled substances to be prescribed via telemedicine for psychiatric treatment (as well as for inpatient, hospice, and nursing home care) (www.flsenate.gov). The only prohibition is for chronic non-malignant pain management—that still requires an in-person exam.

What this means:

• A Florida-licensed psychiatrist can initiate ADHD stimulants or anti-anxiety medications in a video visit with a Florida patient. No in-person visit required.
• This is a carved-out exception in Florida law, recognizing the importance of remote mental health care.

For PMHNPs in Florida:
It’s more complicated. Florida allows certain nurse practitioners to practice autonomously—but only in primary care (family medicine, internal medicine, pediatrics). Psychiatric NPs were excluded from the 2020 autonomous practice law (www.npschools.com).

PMHNPs in Florida must practice under a physician’s protocol. They can prescribe controlled substances, but with limitations:

• Schedule II prescriptions are generally capped at 7 days—except for ‘psychiatric nurses’ treating mental illness with psychotropic medications. If you’re a certified PMHNP with 2+ years of experience under a psychiatrist, you’re exempt from the 7-day limit on psychiatric meds (www.flsenate.gov).
• You must have a collaborating psychiatrist to prescribe psychotropic controlled substances.

Bills to extend autonomous practice to psychiatric NPs (like 2024’s HB 771) have been introduced but haven’t passed (www.flsenate.gov). Until they do, Florida PMHNPs remain under physician oversight.

The gap: Florida desperately needs psychiatric prescribers. With a psychiatrist-to-population ratio of roughly 1:9,000 (www.healingpsychiatryflorida.com), telehealth could expand access—but only if PMHNPs can practice with the same autonomy as psychiatrists. Right now, they can’t.

Texas: Strict Supervision for PMHNPs, Open Telehealth for MDs

Texas is a restricted practice state for nurse practitioners. PMHNPs in Texas must have a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe any medication, including psychiatric drugs (www.bon.texas.gov). There is no pathway to independent practice, regardless of experience.

Additional restrictions:

• Texas NPs generally cannot prescribe Schedule II controlled substances in outpatient settings (with narrow exceptions for terminal illness or emergencies) (www.cchpca.org). This means many Texas PMHNPs rely on their supervising psychiatrist to write initial prescriptions for stimulants.
• The supervising physician can oversee no more than 7 NPs/PAs at once (capitol.texas.gov).
• NPs must have monthly face-to-face meetings with their supervising physician for the first 3 years, then quarterly thereafter (www.legis.state.tx.us).

For psychiatrists:
Texas law allows telemedicine prescribing if the standard of care is met. The state prohibits teleprescribing of opioids for chronic pain, but there’s no restriction on prescribing stimulants or other controlled substances for mental health treatment via telehealth (www.cchpca.org). A Texas-licensed psychiatrist can manage ADHD or anxiety entirely through video visits, as long as they check the state’s Prescription Drug Monitoring Program (PMP) before prescribing controlled substances.

The reality: Texas has 380 mental health professional shortage areas and needs over 600 additional psychiatrists (www.healingpsychiatryflorida.com). Telehealth could help—but the state’s restrictive NP laws mean PMHNPs function more like physician extenders than independent providers. If you’re a PMHNP considering Texas, expect to work under a supervising psychiatrist or within a group practice that provides one.

New York: Independence After 3,600 Hours

New York offers a transition-to-independence model for PMHNPs. New graduates must practice under a written collaborative agreement with a physician (often a psychiatrist) for their first 3,600 hours of practice—roughly 2 years full-time (www.jdsupra.com).

After hitting that threshold, they can practice independently—no written agreement, no chart review, no supervision (www.jdsupra.com). They’re only required to maintain a ‘collaborative relationship’ with physicians (an informal attestation for referrals and consultation), but there’s no legal tether to a specific doctor.

For controlled substances via telehealth:
New York recently finalized regulations aligning state law with federal DEA allowances for teleprescribing (www.nixonpeabody.com). As long as the federal DEA waiver is in effect, New York providers can prescribe controlled substances via telehealth. The state won’t impose additional barriers beyond federal rules.

Reimbursement: New York has strong telehealth parity—all insurers must cover telehealth mental health services at the same rate as in-person. Medicare patients have a minor requirement for an in-person visit every 12 months (currently paused), but that’s a billing rule, not a state law.

The upshot: New York is one of the best states for experienced PMHNPs to practice telehealth psychiatry independently. If you’ve been practicing for a couple of years, you can see patients, prescribe stimulants or SSRIs, and bill insurance—all without a supervising psychiatrist.

California: Transitioning to Full Independence by 2026

California is in the middle of a major shift in NP scope of practice thanks to AB 890 (2020). The law created two new NP certifications:

• 103 NP (effective January 2023): NPs with 3+ years of experience can practice without physician supervision in certain collaborative settings (like group practices or clinics). They still need physicians on staff, but not direct oversight (www.rn.ca.gov).
• 104 NP (effective January 2026): Experienced NPs can practice fully independently, even in solo practice, with no physician involvement (www.rn.ca.gov).

New graduate NPs still need to work under standardized procedures (physician-supervised protocols) for their first 3 years. But after that, they can apply for 103/104 certification and gain independence.

For telehealth:
California allows prescribing via telehealth with a ‘good faith exam’—and telehealth counts (natlawreview.com). Psychiatrists and experienced PMHNPs can prescribe controlled substances via video evaluation under the federal DEA waiver. California requires checking the state’s prescription monitoring program (CURES) before prescribing Schedule II-IV drugs.

The gap: California has over 11 million residents in mental health professional shortage areas (www.healingpsychiatryflorida.com), despite having more psychiatrists per capita than Texas or Florida. Telehealth and expanded NP independence could help meet demand—but it’ll take until 2026 for the full impact of AB 890 to play out.

Pennsylvania: Still Requires Collaboration

Pennsylvania remains a reduced practice state. PMHNPs must have a collaborative agreement with a physician indefinitely—there’s no experience-based pathway to independence (www.pacnp.org).

Prescribing requirements:

• The collaborative agreement must detail which drugs the NP can prescribe.
• NPs can prescribe Schedule II-V controlled substances if the physician delegates it, but initial Schedule II prescriptions are limited to 30 days, and the physician must be notified within 24 hours (www.pacnp.org).
• The physician must review a certain percentage of the NP’s charts (often 10% every 3 months) and meet at least twice a year.

Legislation to grant full practice authority has been introduced but hasn’t passed. Until it does, Pennsylvania PMHNPs must work with a collaborating physician to prescribe.

For psychiatrists:
No restrictions. Pennsylvania psychiatrists can practice telehealth and prescribe controlled substances under federal and state law.

Illinois: Transition to Full Practice Authority

Illinois allows PMHNPs to earn Full Practice Authority after completing 4,000 hours of practice under a collaborative agreement (roughly 2 years) plus 250 hours of continuing education in advanced pharmacology (www.nursepractitionerlicense.com).

Once they earn FPA, they can prescribe independently, including controlled substances (after applying for their own mid-level controlled substance registration).

Until then:

• NP prescriptions must be under the delegated authority of their supervising physician (the physician’s name must appear on scripts).
• They can prescribe Schedule III-V with physician delegation, and Schedule II for up to 30 days in consultation with the physician.

Telehealth: Illinois has strong telehealth support. A 2021 law requires private insurers to reimburse telehealth services at parity through at least 2027 for behavioral health. Medicaid also covers tele-mental health at the same rate as in-person.

The upshot: Illinois is friendly to experienced PMHNPs—they just need to put in the hours under supervision first. Once they achieve FPA, they can practice telehealth psychiatry as independently as an MD.

Psychiatrist vs PMHNP: What’s the Scope Difference?

Let’s be clear about the differences:

Psychiatrists (MD/DO):

• Full, unrestricted prescribing authority in all 50 states.
• No supervision or collaboration requirements.
• Can prescribe any psychiatric medication, including all controlled substances (Schedule II-V).
• Only need state medical licensure and DEA registration.

PMHNPs:

• Prescribing authority varies by state.
• In Full Practice Authority states (34 states + DC as of 2025 (www.nursepractitioneronline.com)), PMHNPs can prescribe independently, including controlled substances, with their own DEA registration.
• In reduced/restricted states (like TX, FL, PA), PMHNPs need a collaborative practice agreement with a physician. These agreements often limit which medications they can prescribe and require periodic chart reviews.
• Reimbursement: Medicare pays NPs at 85% of physician rates when billing under the NP’s own NPI (www.nursepractitioneronline.com). Some private insurers pay at parity; others follow the 85% rule.

What this means for practice:
If you’re a psychiatrist, you can practice telehealth in any state where you hold a license, prescribe freely, and bill at full rates. If you’re a PMHNP, your ability to prescribe independently—and what you can prescribe—depends entirely on state law. In states like New York or Illinois (after meeting experience requirements), you function almost identically to a psychiatrist. In Texas or Florida, you’ll need a collaborating physician, and your prescribing may be more limited.

Reimbursement for Telehealth Medication Management

One of the biggest concerns for providers is whether telehealth pays as well as in-person visits. The short answer: yes, for mental health services in 2026.

Medicare:

• Medicare pays the same for telehealth psychiatry visits as in-person visits (due to telehealth parity policies extended through at least 2025).
• Common reimbursement rates for 2026:
• 90792 (initial psychiatric evaluation with medication management): ~$173 (therathink.com)
• 99213 (15-minute med check): ~$95 (therathink.com)
• 99214 (25-minute med check): ~$136 (therathink.com)
• Medicare also reimburses audio-only mental health services (for patients without video access) at the same rate as in-person.

Private Insurance:
Many states have enacted telehealth parity laws requiring insurers to cover telehealth at the same rate as in-person for behavioral health. Examples:

• Illinois: SB 667 (2021) mandates equal reimbursement for telehealth through at least 2027.
• California: AB 744 (2019) requires payment parity for telehealth.
• New York: Telehealth coverage parity for mental health services.

In practice, most commercial insurers pay $150-200 for a 20-30 minute psychiatric med check via telehealth—often more than Medicare.

Medicaid:
Medicaid reimbursement varies by state but tends to be lower than Medicare or commercial rates. However, many state Medicaid programs have expanded telehealth coverage for mental health and pay at the same rate as in-person. Examples: New York Medicaid, Pennsylvania Medicaid, and California Medi-Cal all cover tele-mental health at parity.

Cash-Pay:
Some psychiatrists—especially those managing ADHD or anxiety—opt for a cash-pay model to avoid insurance hassles. Typical cash rates for a 20-30 minute medication management visit: $100-200. Platforms like Klarity Health often use a hybrid model where providers can see both insurance and cash-pay patients, maximizing revenue while maintaining flexibility.

Why Collaborative Agreements Are a Pain Point for PMHNPs

If you’re a PMHNP in a restricted practice state, finding and maintaining a collaborating physician is one of the biggest administrative burdens you’ll face.

Common requirements:

• Written agreement detailing your scope of practice and which medications you can prescribe.
• Chart reviews: The physician must review a percentage of your charts (10-20%) on a regular basis (monthly or quarterly).
• Periodic meetings: Some states require face-to-face meetings between the NP and physician (e.g., Texas requires monthly meetings for the first 3 years).
• Specialty matching: Some states require the collaborating physician to be in the same specialty. Florida, for example, requires a psychiatrist to collaborate with a PMHNP prescribing psychotropic medications (www.flsenate.gov).

The cost:
Many physicians charge a fee to serve as a collaborator—anywhere from $500 to $2,000+ per month, depending on the state and scope of oversight required. For a new PMHNP building a patient panel, that’s a significant upfront cost.

The opportunity:
Platforms like Klarity Health remove this headache by providing built-in collaborative agreements and physician oversight where required. If you’re practicing in a restricted state, joining a platform that handles the compliance side lets you focus on seeing patients instead of chasing down a collaborator.

The Business Case: Why Telehealth Psychiatry Works Financially

Let’s talk about patient acquisition cost—because this is where telehealth platforms like Klarity Health have a huge advantage over DIY marketing.

The reality of traditional patient acquisition:
If you’re building a private practice from scratch, acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ when you factor in:

• Agency or consultant fees
• Google Ads (mental health keywords cost $15-40+ per click; most clicks don’t convert)
• SEO investment (takes 6-12 months to generate meaningful traffic)
• Directory listings (Psychology Today, Zocdoc) with monthly fees and per-booking charges
• Staff time to handle and qualify leads
• No-show rates from cold leads

Most solo providers don’t have the expertise, budget, or patience to run effective marketing campaigns. And even if they do, there’s no guarantee of results.

The Klarity Health model:
Klarity uses a pay-per-appointment model where providers pay a standard listing fee per new patient lead—similar to Zocdoc, but with key advantages:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients

The ROI: Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. gambling on marketing channels.

For providers starting out or scaling up, Klarity removes the risk entirely. You’re not paying for clicks or waiting months for SEO to kick in—you’re getting patients, now, at a predictable cost per appointment.

Final Takeaways: What You Can (and Can’t) Do in Telehealth Psychiatry

Psychiatrists (MD/DO):

• You can prescribe any psychiatric medication via telehealth, including controlled substances, under current federal DEA waivers (through at least December 31, 2025).
• You must be licensed in the state where the patient is located at the time of the visit.
• You must check the state’s prescription monitoring program (PMP) before prescribing controlled substances.
• Reimbursement is strong—Medicare and most private insurers pay at parity with in-person visits.
• Stay alert for DEA rule changes in late 2024/early 2025 that could re-impose some in-person requirements for controlled substances.

PMHNPs:

• Your prescribing authority depends entirely on state law:
• In Full Practice Authority states (34 states + DC), you can prescribe independently, including controlled substances, after obtaining your own DEA registration.
• In reduced practice states (NY, IL after 3,600-4,000 hours), you need initial physician collaboration but can eventually practice independently.
• In restricted states (TX, FL, PA), you need a collaborative agreement with a physician indefinitely, and your prescribing may be limited (especially for Schedule II drugs).
• Reimbursement: Expect 85% of physician rates for Medicare; some private insurers pay at parity.
• Finding a collaborating physician in restricted states can be expensive and time-consuming—platforms that provide this infrastructure are worth considering.

For both:

• Telehealth psychiatry is financially viable in 2026 thanks to telehealth parity laws and strong demand for psychiatric services.
• Patient acquisition through DIY marketing is expensive and uncertain. Platforms like Klarity Health offer a smarter economic model: pay-per-appointment, pre-qualified patients, no upfront marketing spend, and built-in telehealth infrastructure.
• Document your visits thoroughly, obtain patient consent for telehealth, and ensure your platform meets HIPAA compliance standards.

Ready to Start Prescribing via Telehealth?

If you’re a psychiatrist or PMHNP looking to expand your practice through telehealth, understanding the regulatory landscape is just the first step. The next step is finding a platform that handles patient acquisition, compliance, and infrastructure—so you can focus on what you do best: providing care.

Klarity Health offers psychiatric providers a turnkey solution:

• Pre-qualified patients matched to your specialty
• Both insurance and cash-pay patient flow
• Built-in telehealth platform (no separate EHR or video software needed)
• Collaborative agreements and physician oversight where required (for PMHNPs in restricted states)
• Pay-per-appointment model—no upfront costs, no monthly fees

Explore how Klarity Health can help you build a sustainable, compliant telehealth psychiatry practice—without the marketing headaches or regulatory guesswork. Join Klarity’s provider network and start seeing patients on your schedule, at your rates, with the infrastructure already in place.

Sources and References

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship